Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study.
Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study.
复制标题
肝细胞癌 R0 肝切除术后切除标本中的组织学肿瘤微坏死是确定辅助 TACE 的一个因素:一项回顾性倾向评分匹配研究。
DOI:
10.1016/j.ijsu.2022.106852
复制
发表时间:
2022-08
影响因子:
15.3
通讯作者:
Tingbo Liang
中科院分区:
文献类型:
--
作者:
Yangyang Wang;Hongbin Ge;Manyi Hu;Changrong Pan;Mao Ye;Dipesh Kumar Yadav;Rujia Zheng;Jiajun Wu;Ke Sun;Meng Wang;Yu Tian;Jinyan Huang;Weiyun Yao;Jingsong Li;Qi Zhang;Tingbo Liang
Tumor micronecrosis is a less investigated pathological feature of hepatocellular carcinoma (HCC). This study was aimed at evaluating the value of micronecrosis for guiding adjuvant transcatheter arterial chemoembolization (TACE) in HCC management.We retrospectively reviewed the data of patients with HCC who underwent curative liver resection in our center from 2014 to 2018. The patients were divided into micronecrosis (+) and micronecrosis (-) groups. In each group, overall survival (OS) and disease-free survival (DFS) were compared between patients who underwent adjuvant TACE and those who did not. Propensity score matching (PSM) was conducted at a ratio of 1:1 to control selection bias. Univariate and multivariate analyses were performed to determine independent prognostic factors. Mass cytometry was applied to compare the immunological status of HCCs between the two groups.A total of 897 patients were included, with 417 and 480 patients in the micronecrosis (+) and micronecrosis (-) groups, respectively. No significant difference was detected in baseline parameters after PSM. In the micronecrosis (+) group, patients who underwent adjuvant TACE had significant longer OS than did those who did not (P = 0.004). However, patients in the micronecrosis (-) group did not benefit from adjuvant TACE. Although adjuvant TACE prolonged the DFS of patients with severe micronecrosis (P = 0.034), it may adversely affect the DFS of patients without micronecrosis (P = 0.131). Multivariate analysis showed that TACE was an independent prognostic factor for patients with micronecrosis but not for those without micronecrosis. The abundance of exhausted and regulatory T cells was significantly higher in patients with micronecrosis.For HCC patients with micronecrosis, adjuvant TACE after curative resection could improve the prognosis, while its survival benefits were limited in HCC patients without micronecrosis. TACE should be selectively performed in patients with micronecrosis, especially those with an Nscore = 2. The immunosuppressive status of HCC patients with micronecrosis may explain the effectiveness of adjuvant TACE in such scinario.
登录
查看更多内容
影响因子:
4.3
作者:
Z. Ren;Zhi-ying Lin;J. Xia;S. Ye;Zeng-chen Ma;Q. Ye;L. Qin;Zhi-quan Wu;Jia Fan;Zhao-You Ta
通讯作者:
Z. Ren;Zhi-ying Lin;J. Xia;S. Ye;Zeng-chen Ma;Q. Ye;L. Qin;Zhi-quan Wu;Jia Fan;Zhao-You Ta
影响因子:
1.5
作者:
Gilles, HoChong;Garbutt, Tonora;Landrum, Jasmine
通讯作者:
Landrum, Jasmine
DOI:
--
发表时间:
2019
期刊:
The Egyptian journal of immunology
影响因子:
--
作者:
Ehsan A. Hassan;Entsar H Ahmed;A. Nafee;Nourhan El-Gafary;H. Hetta;M. El-Mokhtar
通讯作者:
Ehsan A. Hassan;Entsar H Ahmed;A. Nafee;Nourhan El-Gafary;H. Hetta;M. El-Mokhtar
影响因子:
9
作者:
Pinna, Antonio Daniele;Yang, Tian;Cucchetti, Alessandro
通讯作者:
Cucchetti, Alessandro
影响因子:
29.4
作者:
Lee, Joon Hyeok;Lee, Jeong-Hoon;Yoon, Jung-Hwan
通讯作者:
Yoon, Jung-Hwan